BackSeres Therapeutics Overview

Seres Therapeutics Current Cash

Track Seres Therapeutics's current cash ($16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$15.59M
↓ 65.64% YoYΔ $-29.79M vs prior year quarter

Peer average / median

Loading

Seres Therapeutics Current Cash History

Loading

Seres Therapeutics vs. peers: Current Cash Comparison

Loading

Seres Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Seres Therapeutics (MCRB) FAQ

Seres Therapeutics (MCRB) currently reports a current cash of $16M as of June 2026. That compares with $45M in the prior-year period — down 65.6% year over year. Use the charts on this page to explore Seres Therapeutics's current cash history and peer comparisons.

Seres Therapeutics's current cash decreased from $45M to $16M — a 65.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seres Therapeutics reported $16M in current cash as of June 2026. That compares with $45M in the prior-year period — down 65.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seres Therapeutics, and consider following MCRB for alerts when major investors trade the stock.

Seres Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MCRB with unrelated industries.